These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8746695

  • 1. Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Gilger BC, Andrews J, Wilkie DA, Wyman M, Lairmore MD.
    Vet Immunol Immunopathol; 1995 Dec; 49(3):199-208. PubMed ID: 8746695
    [Abstract] [Full Text] [Related]

  • 2. Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
    Izci C, Celik I, Alkan F, Ogurtan Z, Ceylan C, Sur E, Ozkan Y.
    Am J Vet Res; 2002 May; 63(5):688-94. PubMed ID: 12013470
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
    Olivero DK, Davidson MG, English RV, Nasisse MP, Jamieson VE, Gerig TM.
    J Am Vet Med Assoc; 1991 Oct 15; 199(8):1039-42. PubMed ID: 1748606
    [Abstract] [Full Text] [Related]

  • 4. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Izci C, Celik I, Alkan F, Erol M, Sur E.
    Biotech Histochem; 2015 Apr 15; 90(3):223-30. PubMed ID: 25747049
    [Abstract] [Full Text] [Related]

  • 5. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
    Gao J, Schwalb TA, Addeo JV, Ghosn CR, Stern ME.
    Cornea; 1998 Nov 15; 17(6):654-63. PubMed ID: 9820947
    [Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
    Ofri R, Lambrou GN, Allgoewer I, Graenitz U, Pena TM, Spiess BM, Latour E.
    Vet J; 2009 Jan 15; 179(1):70-7. PubMed ID: 17950639
    [Abstract] [Full Text] [Related]

  • 7. [Keratoconjunctivitis sicca (KCS) in dogs].
    Tijdschr Diergeneeskd; 2005 Nov 15; 130(22):703-4. PubMed ID: 16335151
    [No Abstract] [Full Text] [Related]

  • 8. Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
    Barachetti L, Rampazzo A, Mortellaro CM, Scevola S, Gilger BC.
    Vet Ophthalmol; 2015 May 15; 18(3):234-41. PubMed ID: 24799029
    [Abstract] [Full Text] [Related]

  • 9. Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K, Balicki I.
    Acta Vet Hung; 2016 Sep 15; 64(3):313-329. PubMed ID: 27653428
    [Abstract] [Full Text] [Related]

  • 10. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
    Morgan RV, Abrams KL.
    J Am Vet Med Assoc; 1991 Oct 15; 199(8):1043-6. PubMed ID: 1748607
    [Abstract] [Full Text] [Related]

  • 11. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP, McHugh JB, Thorne JG, Phillips TE.
    Invest Ophthalmol Vis Sci; 2001 Mar 15; 42(3):653-9. PubMed ID: 11222523
    [Abstract] [Full Text] [Related]

  • 12. Lack of effects on lymphocyte function from chronic topical ocular cyclosporine medication: a prospective study.
    Williams DL.
    Vet Ophthalmol; 2010 Sep 15; 13(5):315-20. PubMed ID: 20840109
    [Abstract] [Full Text] [Related]

  • 13. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
    Kaswan RL, Salisbury MA, Ward DA.
    Arch Ophthalmol; 1989 Aug 15; 107(8):1210-6. PubMed ID: 2757551
    [Abstract] [Full Text] [Related]

  • 14. A new perspective on canine keratoconjunctivitis sicca. Treatment with ophthalmic cyclosporine.
    Kaswan RL, Salisbury MA.
    Vet Clin North Am Small Anim Pract; 1990 May 15; 20(3):583-613. PubMed ID: 2194349
    [Abstract] [Full Text] [Related]

  • 15. The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs.
    Murphy CJ, Bentley E, Miller PE, McIntyre K, Leatherberry G, Dubielzig R, Giuliano E, Moore CP, Phillips TE, Smith PB, Prescott E, Miller JM, Thomas P, Scagliotti R, Esson D, Gadek T, O'Neill CA.
    Invest Ophthalmol Vis Sci; 2011 May 16; 52(6):3174-80. PubMed ID: 21330663
    [Abstract] [Full Text] [Related]

  • 16. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
    Berdoulay A, English RV, Nadelstein B.
    Vet Ophthalmol; 2005 May 16; 8(4):225-32. PubMed ID: 16008701
    [Abstract] [Full Text] [Related]

  • 17. A comparative approach to topical cyclosporine therapy.
    Williams DL.
    Eye (Lond); 1997 May 16; 11 ( Pt 4)():453-64. PubMed ID: 9425407
    [Abstract] [Full Text] [Related]

  • 18. Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine.
    Bounous DI, Krenzer KL, Kaswan RL, Hirsh SG.
    Adv Exp Med Biol; 1998 May 16; 438():997-1000. PubMed ID: 9635001
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K, Balicki I, Szadkowski M.
    Acta Vet Hung; 2018 Jun 16; 66(2):189-203. PubMed ID: 29958527
    [Abstract] [Full Text] [Related]

  • 20. Assessment of tear film osmolarity using the TearLab™ osmometer in normal dogs and dogs with keratoconjunctivitis sicca.
    Sebbag L, Park SA, Kass PH, Maggs DJ, Attar M, Murphy CJ.
    Vet Ophthalmol; 2017 Jul 16; 20(4):357-364. PubMed ID: 27761982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.